IL6 and metabolic syndrome: We demonstrated that the non-traditional cardiovascular risk factors, the TG/HDL ratio, IL-2, IL-6, IL-17A, and INF-γ, were significantly increased in children with MetS than those without MetS, and may therefore be used as biomarkers to predict future cardiovascular disease.